[HTML][HTML] Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
S Auerbach, B Puka, U Golla, I Chachoua - Life, 2024 - mdpi.com
Secondary acute myeloid leukemia (sAML) is a heterogeneous malignant hematopoietic
disease that arises either from an antecedent hematologic disorder (AHD) including …
disease that arises either from an antecedent hematologic disorder (AHD) including …
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
L Zhao, J Yang, M Chen, X Xiang, H Ma, T Niu… - Annals of …, 2024 - Springer
Abstract Venetoclax (VEN), a BCL-2 inhibitor, has transformed treatment strategies for
elderly and unfit acute myeloid leukemia (AML) patients by significantly improving response …
elderly and unfit acute myeloid leukemia (AML) patients by significantly improving response …